
Georgia CORE has launched a comprehensive web site for cancer patients and their families providing current information on cancer treatments, doctors, centers and resources throughout the state.
“GeorgiaCancerInfo.org is the first and only comprehensive source of information on Georgia-based cancer care,” said Nancy M. Paris, president and CEO of Georgia CORE. “With real-time updates on all things related to cancer treatments and resources in Georgia, and as a partner to the National Cancer Institute for information dissemination, patients can rest assured that answers found here are reliable.”
Developed over a two-year process, Georgia CORE worked with cancer care professionals throughout the state to build the web site.
Created for patients, caregivers and professionals, GeorgiaCancerInfo.org provides up-to-date info on:
- Oncologists practicing in Georgia with detailed information, including area of specialty, educational background, certification, research interests and more.
- Hospitals and cancer centers all around the state.
- Cutting-edge cancer treatments, including hundreds of cancer clinical trials, allowing visitors to search by cancer type, location or provider.
- Cancer diagnosis and research news extracted from an array of trusted professional, consumer and advocacy sources.
- Added assistance and resources for cancer care, including screening centers and support groups, resources for transportation, financial aid and accessories.
“Some of the top cancer care experts in the country are right here in Georgia,” said Paris. “This site brings together their collective knowledge, listing every clinical trial and all the cutting-edge cancer research happening here at any given time.”
The first-of-its-kind site is made possible through charitable corporate partners in Georgia’s healthcare industry, some of which provided financial support for the development of the site, and additional partners that are coming on daily for its maintenance as it evolves and is continually updated.
GeorgiaCancerInfo.org has the unique distinction of being approved by the National Cancer Institute.